Gene Biotherapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Gene Biotherapeutics, Inc. reported Increase (Decrease) in Other Noncurrent Assets of $7.07 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2022-04-14
- Gene Biotherapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2020-12-31 was $0.00.
- Gene Biotherapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2020-09-30 was -$19.00.
- Gene Biotherapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2020 was $7.07K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-04-14 | -$19.00 derived: sum of 2 quarters · filed 2022-04-14 | $7.07K 10-K/A · filed 2022-04-14 | |
| 2020-09-30 | -$19.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $7.07K 10-Q · filed 2021-10-27 | ||
| 2020-06-30 | $7.09K 10-Q · filed 2021-09-17 | |||
| 2015-09-30 | -$9.99K 10-Q · filed 2017-03-21 | |||
| 2014-09-30 | -$60.00K 10-Q · filed 2016-10-27 |